29 July 2021 | News
Six startups will spend six months with healthcare industry experts from within and outside GE
Image Credit: Shutterstock
Recognising the emergent need for next-generation technologies and diagnostic solutions in oncology, cardiology, genomics and remote patient monitoring, GE Healthcare’s India Edison Accelerator has announced its Cohort 3 comprising six startup companies from these areas.
Based out of India and Singapore, these companies- 4basecare, Haystack Analytics, zMed Healthcare Technologies, Tricog, AIRA Matrix and Qritive - will spend six months with healthcare industry experts from within and outside GE who will help them build and scale up their solutions for new market segments.
Girish Raghavan, VP, Engineering – GE Healthcare South Asia said, “At the India Edison Accelerator we collaborate with innovators to develop technologies that facilitate access while improving operational efficiency and clinical outcomes. Over the next six months, the startups will work alongside GE’s healthcare engineers and scientists to make their healthcare solutions accessible to more communities around the world.”
Dr Shravan Subramanyam, President and CEO, GE Healthcare – India & South Asia region and Managing Director – Wipro GE Healthcare said, “The startups in Cohort 3 have smart artificial intelligence and machine learning solutions. When integrated with the Edison platform, these solutions can scale up to help doctors, clinicians, care professionals and ultimately patients.”
Applications from startups for Cohort 3 were shortlisted using evaluation criteria such as the strength of the business idea, maturity of product and team capabilities, among others. The India Edison Accelerator provides startups with mentorship, skill development programmes, commercial and regulatory guidance as well as data provisioning.